These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36323381)

  • 1. Pathophysiological characterization of the Townes mouse model for sickle cell disease.
    Alvarez-Argote J; Dlugi TA; Sundararajan T; Kleynerman A; Faber ML; McKillop WM; Medin JA
    Transl Res; 2023 Apr; 254():77-91. PubMed ID: 36323381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
    Nyffenegger N; Zennadi R; Kalleda N; Flace A; Ingoglia G; Buzzi RM; Doucerain C; Buehler PW; Schaer DJ; Dürrenberger F; Manolova V
    Blood; 2022 Aug; 140(7):769-781. PubMed ID: 35714304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models.
    Saraf SL; Sysol JR; Susma A; Setty S; Zhang X; Gudehithlu KP; Arruda JAL; Singh AK; Machado RF; Gordeuk VR
    Transl Res; 2018 Jul; 197():1-11. PubMed ID: 29476712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.
    Demers M; Sturtevant S; Guertin KR; Gupta D; Desai K; Vieira BF; Li W; Hicks A; Ismail A; Gonçalves BP; Di Caprio G; Schonbrun E; Hansen S; Musayev FN; Safo MK; Wood DK; Higgins JM; Light DR
    Blood Adv; 2021 Mar; 5(5):1388-1402. PubMed ID: 33661300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired hemoglobin clearance by sinusoidal endothelium promotes vaso-occlusion and liver injury in sickle cell disease.
    Kaminski TW; Katoch O; Li Z; Hanway CB; Dubey RK; Alagbe A; Brzoska T; Zhang H; Sundd P; Kato GJ; Novelli EM; Pradhan-Sundd T
    Haematologica; 2024 May; 109(5):1535-1550. PubMed ID: 37941440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
    Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
    PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes.
    Brittenham GM; Schechter AN; Noguchi CT
    Blood; 1985 Jan; 65(1):183-9. PubMed ID: 3965046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
    Wen J; Tao W; Hao S; Zu Y
    J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxia.
    Abdulmalik O; Darwish NHE; Muralidharan-Chari V; Taleb MA; Mousa SA
    Haematologica; 2022 Feb; 107(2):532-540. PubMed ID: 33567814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity.
    Fabry ME; Sengupta A; Suzuka SM; Costantini F; Rubin EM; Hofrichter J; Christoph G; Manci E; Culberson D; Factor SM; Nagel RL
    Blood; 1995 Sep; 86(6):2419-28. PubMed ID: 7662990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of alpha-thalassemia and sickle polymerization tendency on the urine-concentrating defect of individuals with sickle cell trait.
    Gupta AK; Kirchner KA; Nicholson R; Adams JG; Schechter AN; Noguchi CT; Steinberg MH
    J Clin Invest; 1991 Dec; 88(6):1963-8. PubMed ID: 1752955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percentage of HbS among cases of sickle-cell trait in Basra, Iraq.
    al-Shakour AA; al-Suhail AA
    East Mediterr Health J; 2000; 6(2-3):233-7. PubMed ID: 11556007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model.
    Quezado ZMN; Kamimura S; Smith M; Wang X; Heaven MR; Jana S; Vogel S; Zerfas P; Combs CA; Almeida LEF; Li Q; Quezado M; Horkayne-Szakaly I; Kosinski PA; Yu S; Kapadnis U; Kung C; Dang L; Wakim P; Eaton WA; Alayash AI; Thein SL
    Blood Cells Mol Dis; 2022 Jul; 95():102660. PubMed ID: 35366607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme Induces IL-6 and Cardiac Hypertrophy Genes Transcripts in Sickle Cell Mice.
    Gbotosho OT; Kapetanaki MG; Ghosh S; Villanueva FS; Ofori-Acquah SF; Kato GJ
    Front Immunol; 2020; 11():1910. PubMed ID: 32973791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbS Binding to GP1bα Activates Platelets in Sickle Cell Disease.
    Annarapu GK; Singhal R; Gupta A; Chawla S; Batra H; Seth T; Guchhait P
    PLoS One; 2016; 11(12):e0167899. PubMed ID: 27936141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Growth Differentiation Factor-15 (GDF-15) levels are increased in patients with compound heterozygous sickle cell and beta-thalassemia (HbS/β
    Larissi K; Politou M; Margeli A; Poziopoulos C; Flevari P; Terpos E; Papassotiriou I; Voskaridou E
    Blood Cells Mol Dis; 2019 Jul; 77():137-141. PubMed ID: 31071550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction.
    D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Gordeuk VR; Gladwin MT
    Am J Hematol; 2023 Jul; 98(7):1017-1028. PubMed ID: 36971592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
    Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
    Front Immunol; 2020; 11():613278. PubMed ID: 33542720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid paper-based test for quantifying sickle hemoglobin in blood samples from patients with sickle cell disease.
    Piety NZ; Yang X; Lezzar D; George A; Shevkoplyas SS
    Am J Hematol; 2015 Jun; 90(6):478-82. PubMed ID: 25689370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.